84 related articles for article (PubMed ID: 30585839)
1. One step closer to ultra-long-acting PREP?
Harper KN
AIDS; 2019 Mar; 33(3):N2. PubMed ID: 30585839
[No Abstract] [Full Text] [Related]
2. Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.
Lykins WR; Luecke E; Johengen D; van der Straten A; Desai TA
Drug Deliv Transl Res; 2017 Dec; 7(6):805-816. PubMed ID: 28612340
[TBL] [Abstract][Full Text] [Related]
3. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
Krakower DS; Mayer KH
Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
[TBL] [Abstract][Full Text] [Related]
4. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
[TBL] [Abstract][Full Text] [Related]
5. Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
John SA; Whitfield THF; Rendina HJ; Parsons JT; Grov C
AIDS Behav; 2018 Apr; 22(4):1184-1189. PubMed ID: 28913659
[TBL] [Abstract][Full Text] [Related]
6. Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention in South Africa: Is There a Will and a Way?
Landovitz RJ; Grinsztejn B
J Infect Dis; 2016 May; 213(10):1519-20. PubMed ID: 26681779
[No Abstract] [Full Text] [Related]
7. Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis.
Yoong D; Naccarato M; Sharma M; Wilton J; Senn H; Tan DH
Int J STD AIDS; 2016 Jul; 27(8):608-16. PubMed ID: 26025254
[TBL] [Abstract][Full Text] [Related]
8. The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women.
Velloza J; Heffron R
Curr HIV/AIDS Rep; 2017 Oct; 14(5):153-160. PubMed ID: 28812207
[TBL] [Abstract][Full Text] [Related]
9. Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
Tetteh RA; Yankey BA; Nartey ET; Lartey M; Leufkens HG; Dodoo AN
Drug Saf; 2017 Apr; 40(4):273-283. PubMed ID: 28130774
[TBL] [Abstract][Full Text] [Related]
10. Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.
Parsons JT; Rendina HJ; Whitfield TH; Grov C
AIDS Behav; 2016 Jul; 20(7):1390-9. PubMed ID: 27000145
[TBL] [Abstract][Full Text] [Related]
11. HIV pre-exposure prophylaxis (PrEP): Is it time to rethink HIV prevention in travelers?
Hampel B; Reinacher M; Fehr JS
Travel Med Infect Dis; 2018; 25():6-7. PubMed ID: 29929002
[No Abstract] [Full Text] [Related]
12. [HIV Pre-Exposure prophylaxis (PrEP) in men].
Spinner CD
MMW Fortschr Med; 2017 Jun; 159(Suppl 2):40-42. PubMed ID: 28597265
[No Abstract] [Full Text] [Related]
13. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
Jain S; Krakower DS; Mayer KH
Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
[TBL] [Abstract][Full Text] [Related]
14. Improving the effectiveness and delivery of pre-exposure prophylaxis (PrEP) to people who inject drugs.
Marshall BD; Milloy MJ
Addiction; 2017 Apr; 112(4):580-582. PubMed ID: 27730702
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
[TBL] [Abstract][Full Text] [Related]
16. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.
Özdener AE; Park TE; Kalabalik J; Gupta R
Expert Rev Anti Infect Ther; 2017 May; 15(5):467-481. PubMed ID: 28322067
[TBL] [Abstract][Full Text] [Related]
17. Implementing HIV pre-exposure prophylaxis (PrEP): let's not get caught with our pants down.
Saxton P; Giola M; Coughlan E; Rich J; Azariah S; Ludlam A; O'Toole C; Pohl M; Myers J
N Z Med J; 2018 Aug; 131(1481):64-73. PubMed ID: 30161114
[TBL] [Abstract][Full Text] [Related]
18. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
[TBL] [Abstract][Full Text] [Related]
19. Preexposure Prophylaxis of HIV Infection: the Role of Clinical Practices in Ending the HIV Epidemic.
Zablotska IB; O'Connor CC
Curr HIV/AIDS Rep; 2017 Dec; 14(6):201-210. PubMed ID: 29071519
[TBL] [Abstract][Full Text] [Related]
20. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.
Marcus JL; Volk JE; Pinder J; Liu AY; Bacon O; Hare CB; Cohen SE
Curr HIV/AIDS Rep; 2016 Apr; 13(2):116-24. PubMed ID: 26898645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
